Seve Ballesteros, Europe’s greatest player, announced his retirement from competition on the eve of the 2007 Open ...
Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2. The new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback